MDxHealth SA (MDXH) News
Track canonical SquawkNews coverage tagged to MDXH, MDxHealth SA. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
MDxHealth reports Q2 revenue growth, raises $20 million
MDxHealth said Q2 2026 revenue was $27.2 million, up 16% year over year and 14% sequentially, while adjusted EBITDA was negative $2.3 million and it raised $20 million in a registered direct placement.
EARNINGS | Aug 13, 2026, 09:14 PM UTC
L
MDxHealth shares rise on better-than-expected Q2 sales, FY26 guidance
MDxHealth shares trade higher after the company reported better-than-expected Q2 sales results and affirmed its FY26 sales guidance above estimates.
EARNINGS | Aug 13, 2026, 08:32 PM UTC
L
MDxHealth affirms FY2026 sales guidance at $110.0M–$115.0M
MDxHealth (NASDAQ: MDXH) affirms FY2026 sales guidance of $110.000M–$115.000M versus a $98.814M estimate.
EARNINGS | Aug 13, 2026, 08:13 PM UTC
L
MDXH reports second-quarter 2026 financial results
Mdxhealth (MDXH) reports its second-quarter 2026 financial results, according to TradeXchange Newsdesk, with no additional figures provided in the feed.
EARNINGS | Aug 13, 2026, 08:00 PM UTC
L
MDXH - Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
MDXH - Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
EARNINGS | Jul 30, 2026, 08:00 PM UTC
L
MDxHealth Gets Nasdaq Non-Compliance Notice
() -- MDxHealth (MDXH) has received a notice from Nasdaq for failing to comply with its minimum bid price listing rule, the company said Thursday. The company has until Dec. 28 to regain compliance. Copyright © 2026. All
EQUITY | Jul 02, 2026, 08:12 PM UTC
L
Mdxhealth Receives Nasdaq Noncompliance Notice, Gets Time Through Dec. 28 To Regain Compliance
Mdxhealth SA (NASDAQ: MDXH ) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the "Notification Letter") from the Listing
EQUITY | Jul 02, 2026, 08:01 PM UTC